Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECREASE-PCI
NCT01346865Phase 4Terminated
- Start
- May 2011
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in coronary artery disease (CAD). Started May 2011; status: terminated.
02
Drugs
cilostazol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01346865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346865.